Amit Munshi - 01 Jun 2023 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Director
Signature
/s/ Kim Davis, Attorney-in-Fact
Issuer symbol
ZURA
Transactions as of
01 Jun 2023
Net transactions value
$0
Form type
4
Filing time
02 Jun 2023, 20:45:24 UTC
Previous filing
21 Mar 2023
Next filing
05 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZURA Employee Share Option (Right to Buy) Award $0 +1,130,000 $0.000000 1,130,000 01 Jun 2023 Class A Ordinary Shares 1,130,000 $6.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted an option to purchase 1,130,000 Class A Ordinary Shares of the Issuer (the "Option") on June 1, 2023 (the "Grant Date"). The Option is vested and nonforfeitable as of the Grant Date. 25% of the Option shall become exercisable on June 1, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter.